A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Optimal Neo-adjuvant Combination Scheme of Ipilimumab and Nivolumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Elotuzumab Safety Surveillance In Japanese Patients With Relapse Or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Evaluating True PCR-negative Rate of Frontline Dasatinib in Early Chronic Phase CML for Therapeutic Harmonization
- Status
- UNKNOWN
- Phase
- N/A
REALM China Extension Study
- Status
- UNKNOWN
- Phase
- N/A
Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy
- Status
- COMPLETED
- Phase
- PHASE3
Study of Combination of Ipilimumab and Nivolumab in Patients With Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Interferon-free Antiviral Treatment of Chronic Hepatitis C Virus Infection Among Opioid-substituted Patients
- Status
- COMPLETED
- Phase
- N/A
A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study of BMS-986016 With or Without Nivolumab in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Nivolumab Safety and Pharmacokinetics in Patients With Severe Sepsis or Septic Shock.
- Status
- COMPLETED
- Phase
- PHASE1
H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study in Which Therapy is Either Switched to Nivolumab After 3 Months of Treatment or Therapy is Continued With a Tyrosine Kinase Inhibitor in Patients With Metastatic Renal Cell Carcinoma (RCC) and Disease Control
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics of BMS-986177 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Dasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR Mutations
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
NeoVax Plus Ipilimumab in Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1